Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
09.03.26 - 06:33
Ascom reports solid 2025 full-year results (GlobeNewswire EN)
 
Ad hoc announcement pursuant to Art. 53 LRBaar, Switzerland, 9 March 2026...
09.03.26 - 04:54
WeRide and Geely Farizon to Deliver 2,000 Purpose-Built Robotaxi GXRs by 2026, Advancing Large-Scale Global Commercialization (GlobeNewswire EN)
 
WeRide today expanded its strategic cooperation with Geely Farizon and announced plans to deliver 2,000 upgraded, purpose‑built Robotaxi GXRs by 2026....
09.03.26 - 04:48
Hinen Introduces 3kW Cost-Effective Off-Grid and 12kW High-Power Hybrid Solutions at Solar & Storage Live Africa 2026 (GlobeNewswire EN)
 
Hinen will showcase its latest residential energy storage solutions at Solar & Storage Live Africa 2026, including new 3kW off-grid and 12kW hybrid systems...
08.03.26 - 23:03
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) (GlobeNewswire EN)
 
- New analyses out to 24-months showed improvement in heart and lung function compared to expected declines in DMD natural history -...
08.03.26 - 23:03
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1) (GlobeNewswire EN)
 
- HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 -...
08.03.26 - 22:03
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (GlobeNewswire EN)
 
NEW YORK and WALTHAM, Mass., March 08, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced a conference call and webcast to discuss the interim responder analysis results from Part A of the Phase 3 CAPTIVATE trial of claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) scheduled for tomorrow, Monday, March 9, 2026 at 8:00 a.m. ET....
08.03.26 - 19:03
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026 (GlobeNewswire EN)
 
VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, will announce topline data from the Phase 3 X-TOLE2 study of azetukalner, a novel, potent KV7 potassium channel opener, in patients with focal onset seizures (FOS), on Monday, March 9, 2026....
07.03.26 - 23:18
A Record-Setting Saturday as Broad Arrow Closes $107M+ $Amelia Concours Auction with $6,605,000 Lamborghini Miura SV (GlobeNewswire EN)
 
Broad Arrow sees enthusiastic bidding from start to finish during second and final day of 2026 Amelia Concours Auction | Saturday led by 1972 Lamborghini Miura P400 SV at $6,605,000, a landslide new world for a Miura at auction | Two-day sale total currently sits in excess of $107 million, Broad Arrow's most successful auction to date | Strong prices and additional records achieved across all segments of the market, most notably for Ferraris and for Americana offered from respected private collections | Complete results will be available at broadarrowauctions.com in coming days Broad Arrow sees enthusiastic bidding from start to finish during second and final day of 2026 Amelia Concours Auction | Saturday led by 1972 Lamborghini Miura P400 SV at $6,605,000, a landslide new world for a Miura at auction | Two-day sale total currently sits in excess of $107 million, Broad Arrow's most successful auction to date | Strong prices and additional records achieved across all segments of the market, most notably ...
07.03.26 - 20:57
Renk Group AG: Sevinc Sagel, Disposal (GlobeNewswire EN)
 
Renk Group AG: Sevinc Sagel, Disposal...
07.03.26 - 20:48
Renk Group AG: Sevinc Sagel, Acquisition (GlobeNewswire EN)
 
Renk Group AG: Sevinc Sagel, Acquisition...
07.03.26 - 03:21
NEWS FLASH: Broad Arrow Smashes World Records with Collection of Unobtanium Supercars on Day One of Amelia Concours Auction (GlobeNewswire EN)
 
Nero 2003 Ferrari Enzo Leads Collection at $15,185,000 | 1988 Porsche 959 Sport Achieves New Record for the Model at $5,505,000 | 2021 Ferrari Monza SP2 Sets New Benchmark at $4,955,000 | 2017 Ferrari F12tdf Reaches New Heights at $4,185,000 | 2015 Porsche 918 Spyder Sells for World Record Price at $2,975,000 | Outside the Collection, Paint-to-Sample 2005 Porsche Carrera GT Doubles Previous Record at $6,715,000 Nero 2003 Ferrari Enzo Leads Collection at $15,185,000 | 1988 Porsche 959 Sport Achieves New Record for the Model at $5,505,000 | 2021 Ferrari Monza SP2 Sets New Benchmark at $4,955,000 | 2017 Ferrari F12tdf Reaches New Heights at $4,185,000 | 2015 Porsche 918 Spyder Sells for World Record Price at $2,975,000 | Outside the Collection, Paint-to-Sample 2005 Porsche Carrera GT Doubles Previous Record at $6,715,000...
07.03.26 - 01:21
AMC Networks Announces Expiration of Consent Solicitation to Amend its 10.50% Senior Secured Notes due 2032 (GlobeNewswire EN)
 
NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) --  AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) announced today the expiration and results of the previously announced and extended consent solicitation (the “Consent Solicitation”) soliciting consents (“Consents”) from the holders of its existing 10.50% Senior Secured Notes due 2032 (the “Notes”) to amend the indenture governing the Notes to (1) amend the covenant that limits restricted payments in order to permit buybacks, purchases, redemptions, retirements or other acquisitions of AMC Networks Inc.'s equity interests in an aggregate amount not to exceed $50,000,000; (2) revise the covenant that limits transfers or licenses of certain trademarks to unrestricted subsidiaries to only permit transfers of non-exclusive licenses; and (3) restrict investments in unrestricted subsidiaries made pursuant to the definition of “Permitted Investments” to certain specified clauses in such definition (the “Amendments”)....
07.03.26 - 01:21
AMC Networks Announces Early Tender Results of Any and All Exchange Offer and Consent Solicitation for its 10.25% Senior Secured Notes due 2029 (GlobeNewswire EN)
 
NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) today announced the early participation and consent results in connection with its previously announced (i) exchange offer (the “Exchange Offer”) to Eligible Holders (as defined below) to exchange any and all of its outstanding 10.25% Senior Secured Notes due 2029 (the “Old Notes”) for its newly-issued 10.50% Senior Secured Notes due 2032 (the “New Notes”), and (ii) the solicitation of consents (the “Consent Solicitation”) from holders of the Old Notes with respect to the amendment (the “Proposed Amendment”) to the indenture governing the Old Notes (the “Old Notes Indenture”) described below, on the terms and subject to the conditions set forth in a Confidential Offering Memorandum and Consent Solicitation Statement, dated as of February 23, 2026 (the “Offering Memorandum”). Capitalized terms not defined herein shall have the respective meanings ascribed to ...
07.03.26 - 01:03
AIM ImmunoTech Announces Closing of its Rights Offering (GlobeNewswire EN)
 
OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – announced today the closing of its previously announced rights offering (the “Rights Offering”). The Rights Offering resulted in total subscriptions of approximately $1.8 million....
07.03.26 - 00:42
Reflex Advanced Announces Closing of Securities for Debt Transactions (GlobeNewswire EN)
 
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
07.03.26 - 00:18
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc. (GlobeNewswire EN)
 
Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per share...
07.03.26 - 00:03
XAI Octagon Floating Rate & Alternative Income Trust Announces 1-For-5 Reverse Stock Split and Effective Date (GlobeNewswire EN)
 
CHICAGO, March 06, 2026 (GLOBE NEWSWIRE) -- XAI Octagon Floating Rate & Alternative Income Trust (NYSE: XFLT) (the “Trust”) today announced that its Board of Trustees has approved the implementation of a 1-for-5 reverse stock split (the “Reverse Stock Split”) of the Trust's common shares of beneficial interest, par value $0.01 per share (the “Common Shares”)....
06.03.26 - 23:36
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
BOSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that, effective February 2, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors granted a non-qualified stock option to purchase 367,500 shares of its common stock and 60,000 restricted stock units (RSUs) to a new employee under Tango Therapeutics' 2023 Inducement Plan....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn jedoch die Kraft, die die menschliche Aktivität bestimmt, nicht die Vernunft ist, bleibt der Mensch unter dem Niveau seiner eigenen Möglichkeiten. - Robert Strange McNamara
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!